These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8680672)

  • 1. The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis.
    Hordvik NL; Sammut PH; Judy CG; Strizek SJ; Colombo JL
    Am J Respir Crit Care Med; 1996 Jul; 154(1):156-60. PubMed ID: 8680672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of standard and high doses of salmeterol on lung function of hospitalized patients with cystic fibrosis.
    Hordvik NL; Sammut PH; Judy CG; Colombo JL
    Pediatr Pulmonol; 1999 Jan; 27(1):43-53. PubMed ID: 10023791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
    Hordvik NL; Sammut PH; Judy CG; Colombo JL
    Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.
    Elkins MR; Robinson M; Rose BR; Harbour C; Moriarty CP; Marks GB; Belousova EG; Xuan W; Bye PT;
    N Engl J Med; 2006 Jan; 354(3):229-40. PubMed ID: 16421364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of albuterol on maximal exercise capacity in cystic fibrosis.
    Serisier DJ; Coates AD; Bowler SD
    Chest; 2007 Apr; 131(4):1181-7. PubMed ID: 17426226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: a preliminary report.
    König P; Gayer D; Barbero GJ; Shaffer J
    Pediatr Pulmonol; 1995 Oct; 20(4):205-14. PubMed ID: 8606849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of albuterol, isoetharine, and metaproterenol given by aerosol inhalation.
    Berezuk GP; Schondelmeyer SW; Seidenfeld JJ; Jones WN; Bootman JL
    Clin Pharm; 1983; 2(2):129-34. PubMed ID: 6349905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of tiotropium on the pulmonary diffusing capacity.
    Gonlugur U
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):535-7. PubMed ID: 18040529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone.
    Regelmann WE; Elliott GR; Warwick WJ; Clawson CC
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):914-21. PubMed ID: 2109558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of salbutamol on gas compression in cystic fibrosis and asthma.
    Desmond KJ; Demizio DL; Allen PD; MacDonald ND; Coates AL
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):673-7. PubMed ID: 8118635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis.
    König P; Poehler J; Barbero GJ
    Pediatr Pulmonol; 1998 Jan; 25(1):32-6. PubMed ID: 9475328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma.
    Spector SL; Nicodemus CF; Corren J; Schanker HM; Rachelefsky GS; Katz RM; Siegel SC
    J Allergy Clin Immunol; 1995 Aug; 96(2):174-81. PubMed ID: 7636054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
    Dodd JD; Barry SC; Daly LE; Gallagher CG
    J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-dose ibuprofen in patients with cystic fibrosis.
    Konstan MW; Byard PJ; Hoppel CL; Davis PB
    N Engl J Med; 1995 Mar; 332(13):848-54. PubMed ID: 7503838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
    Laube BL; Auci RM; Shields DE; Christiansen DH; Lucas MK; Fuchs HJ; Rosenstein BJ
    Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
    Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
    Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.